Joanne Wuensch News
-
Edwards Lifesciences Corp., the biggest-maker of aortic heart valves implanted with a catheter, plunged the most in a dozen years after the company cut its 2013 forecast on slower-than-anticipated sales.
-
CareFusion Corp.’s medical pumps, ventilators and medicine dispensers have already attracted the attention of investors who sent the company’s stock to a record last week. Now, it could get a look from private-equity firms.
-
The insulation coating on St. Jude Medical Inc.’s Durata lead, used to connect a life-saving defibrillator to the heart, can fray when it rubs against another object, according to a study that didn’t raise substantial new concerns about the device.
-
Stryker Corp. Chief Executive Officer Stephen MacMillan led the company’s expansion efforts and helped the maker of artificial hips and knees navigate an industrywide probe before his resignation yesterday for family reasons.
-
CareFusion Corp., the maker of infusion pumps and hospital products, dropped the most in two years after second-quarter profit missed analyst estimates and the company lowered the bottom end of its full-year forecast.
-
Johnson & Johnson’s pursuit of growth through acquisitions could put companies from Edwards Lifesciences Corp. to St. Jude Medical Inc. on its wish list.
-
C.R. Bard Inc., maker of catheters and surgical devices, dropped as much as 6.3 percent in New York trading after its 2012 profit forecast missed analyst estimates.
-
Covidien Plc., a maker of surgical products and drugs, plans to spin off its pharmaceuticals division into a separate company that would be better able to compete in the growing pain-management area.
-
Covidien Plc agreed to buy Oridion Systems Ltd., an Israeli maker of devices for patient breathing safety, for $346 million.
-
Patients undergoing hip-replacement surgery are being released earlier, while more make return trips to the hospital within 30 days of the procedure, an analysis of Medicare recipients found.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page